These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3924609)
1. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A. Klinger KW; Shuster CW; Klinger J Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609 [TBL] [Abstract][Full Text] [Related]
2. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. Jagger KS; Robinson DL; Franz MN; Warren RL J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay. Klinger JD; Straus DC; Hilton CB; Bass JA J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596 [TBL] [Abstract][Full Text] [Related]
4. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of serum antibody responses to Pseudomonas aeruginosa exotoxin A by cystic fibrosis and intensive care unit patients. Cukor G; Blacklow NR; Nowak NA; Rich CM; Braverman LE; Fischer RA J Clin Microbiol; 1983 Sep; 18(3):457-62. PubMed ID: 6415090 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060 [TBL] [Abstract][Full Text] [Related]
7. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A. Klinger KW; Shuster CW Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741 [TBL] [Abstract][Full Text] [Related]
8. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125 [TBL] [Abstract][Full Text] [Related]
9. Antibody response to Pseudomonas aeruginosa exoproducts in cancer patients. Crowe KE; Bass JA; Young VM; Straus DC J Clin Microbiol; 1982 Jan; 15(1):115-22. PubMed ID: 6821202 [TBL] [Abstract][Full Text] [Related]
10. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Cryz SJ; Lang A; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Schaad U Behring Inst Mitt; 1997 Feb; (98):345-9. PubMed ID: 9382759 [TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa antibody detection in cystic fibrosis patients. Trancassini M; De Vito D; Quattrucci S; Cipriani P New Microbiol; 1999 Apr; 22(2):85-9. PubMed ID: 10322606 [TBL] [Abstract][Full Text] [Related]
12. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa. Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197 [TBL] [Abstract][Full Text] [Related]
13. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies. Coin D; Vacheron MJ; Guinand M; Michel G FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130 [TBL] [Abstract][Full Text] [Related]
14. [Serodiagnosis of Pseudomonas aeruginosa infections in mucoviscidosis: comparative study of Western blotting, ELISA exotoxin A and ELISA phospholipase C]. Fournier C; Andre J; Marlier H; Guinet R; Gilly R Pathol Biol (Paris); 1993 Nov; 41(9):856-64. PubMed ID: 8121717 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Pollack M; Longfield RN; Karney WW Am J Med; 1983 Jun; 74(6):980-7. PubMed ID: 6407308 [TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa serological analysis in young children with cystic fibrosis diagnosed through newborn screening. Hayes D; Farrell PM; Li Z; West SE Pediatr Pulmonol; 2010 Jan; 45(1):55-61. PubMed ID: 20025049 [TBL] [Abstract][Full Text] [Related]
17. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A]. Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613 [TBL] [Abstract][Full Text] [Related]
18. [Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A]. Egizova SA; Deriabin PN; Karal'nik BV; Kanapina ASh; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):38-41. PubMed ID: 3149841 [TBL] [Abstract][Full Text] [Related]
19. Characterization of antibody response to Pseudomonas aeruginosa in patients with wound infections. Trafny EA; Grzybowski J; Patzer J; Popiel D; Wrembel-Wargocka J; Dzierzanowska D; Zawistowska-Marciniak I; Kobus K Microbiol Immunol; 1991; 35(6):435-42. PubMed ID: 1921760 [TBL] [Abstract][Full Text] [Related]
20. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections. Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]